Safety and Efficacy of Beclomethasone Dipropionate in Patients At Least 12 Years Old With Asthma

- Persistent Asthma
- Completed

Study Title: A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma

Teva Identifier: BDB-AS-304

ClinicalTrials.gov Identifier: NCT02040779

Study Status: Completed

Trial Condition(s): Persistent Asthma

Interventions: Drug: Beclomethasone dipropionate breath-actuated inhaler | Drug: Placebo breath-actuated inhaler | Drug: albuterol/salbutamol

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child, Adult, Older Adult

Age Range: 12 Years and older

Trial Duration: December 26, 2013 - December 24, 2014

Phase: Phase 3

Study Type

Interventional